Wednesday, June 17, 2026

Latest

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Silver’s Next Move May Be Built on a Much Stronger Base | Mani Alkhafaji – First Majestic Silver

Guanajuato Silver Q1 Earnings: They Finally Post Positive Net Income

We’re in a New Era of Gold Price Discovery | Ryan King – Equinox Gold

Recommended

Antimony Resources Drills 5.45% Antimony Over 10.3 Metres At Bald Hill

PTX Metals Hits 92% Copper Recovery in Debut W2 Testwork

Related News

How Do Trump Stock Filings Expose Big Tech Conflict Questions

President Donald Trump’s stock disclosures have turned Big Tech exposure into a White House ethics...

Tuesday, May 19, 2026, 01:01:56 PM

Elon Musk Sends His Starlink To Fix FAA After Trump’s Massive Layoffs

Elon Musk has offered his SpaceX Starlink satellite internet technology to the Federal Aviation Administration,...

Saturday, March 1, 2025, 07:38:00 AM

More Trump Tariffs Coming: 25% On Steel And Aluminum

Tariffs are back after President Donald Trump announced that he will apply a 25% levy...

Monday, February 10, 2025, 03:50:00 PM

Countertariffs and Severed Ties: How Nations Are Responding To Trump’s Tariffs

The escalating series of trade tariffs by President Donald Trump has drawn swift and forceful...

Friday, April 4, 2025, 03:03:00 PM

Canadians Back Pipeline Expansion as US Trade Tensions Rise

Four in five Canadians (79%) support expanding the country’s pipeline network from coast to coast...

Friday, February 7, 2025, 12:10:00 PM